WCG
HAE icon

Weaver Consulting Group’s Haemonetics HAE Stock Holding History

Weaver Consulting Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-28
Closed -$2K – 446
2020
Q3 		$2K Hold
28
– – ﹤0.01% 824
2020
Q2 		$3K Hold
28
– – ﹤0.01% 742
2020
Q1 		$3K Hold
28
– – ﹤0.01% 648
2019
Q4 		$4K Hold
28
– – ﹤0.01% 643
2019
Q3 		$4K Hold
28
– – ﹤0.01% 627
2019
Q2 		$3K Hold
28
– – ﹤0.01% 655
2019
Q1 		$3K Buy
+28
New +$2.55K ﹤0.01% 1229

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Weaver Consulting Group's HAE Position: Q4 2020 in Review

Weaver Consulting Group sold out of Haemonetics (HAE) in Q4 2020, closing a stake of 28 shares — an estimated $2K sold.

Weaver Consulting Group first reported a position in HAE in Q1 2019 and held it in 7 quarters. The position peaked at $4K in Q4 2019. 286 funds tracked by Wall St. Rank hold HAE as of Q4 2020.

  • Weaver Consulting Group reported no remaining Haemonetics position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 28 Haemonetics shares in Q4 2020, an estimated $2K.
  • Weaver Consulting Group first reported a position in Haemonetics in Q1 2019 and held it in 7 quarters.
  • Weaver Consulting Group's Haemonetics position peaked at $4K in Q4 2019.
  • 286 funds tracked by Wall St. Rank held Haemonetics as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.